Printer Friendly

GLAXO INC. NAMES VICE PRESIDENT AND GENERAL MANAGER OF NEW DIVISION

 GLAXO INC. NAMES VICE PRESIDENT AND GENERAL MANAGER OF NEW DIVISION
 RESEARCH TRIANGLE PARK, N.C., Jan. 13 /PRNewswire/ -- George Morrow, former vice president of marketing for Merck Sharp & Dohme, will join Glaxo Inc. as vice president and general manager of the pharmaceutical firm's new central nervous system sales and marketing division.
 The division, part of the company's Glaxo Pharmaceuticals strategic business unit, initially will oversee the marketing of Zofran(R) (ondansetron), which prevents nausea and vomiting associated with cancer chemotherapy. It also will have responsibility for Imitrex(R) (sumatriptan), Glaxo's migraine therapy currently under review at the Food and Drug Administration, and other therapies for central nervous system conditions as they are approved for marketing by federal authorities.
 Formerly a high school and college chemistry instructor, Morrow, 39, began his career with Merck as a sales representative, moving into a series of increasingly responsible positions in market research, business development and planning, and hospital marketing.
 He holds a bachelor's degree in chemistry from Southampton College on Long Island, a master's degree in biochemistry from Bryn Mawr, and an M.B.A. from Duke University's Fuqua School of Business.
 "Our pipeline is rich in products with potential central nervous symptom indications," said Charles A. Sanders, M.D., chairman and chief executive officer of Glaxo Inc. "We are fortunate to have an executive of George's caliber to lead the team that will translate our remarkable success in drug discovery into important and innovative products in the marketplace."
 Morrow, his wife Katherine and their three children will relocate to the Triangle area.
 -0- 1/13/91
 /CONTACT: Rick Sluder, Corporate Communications, Glaxo Inc., 919-248-2839/ CO: Glaxo Inc. ST: North Carolina IN: MTC SU: PDT PER


DF -- CH005 -- 9117 01/13/92 12:58 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 13, 1992
Words:292
Previous Article:ELECTRO RENT DECLARES 3-FOR-2 STOCK SPLIT
Next Article:UNION TEXAS PETROLEUM SELLS INTEREST IN ONSHORE ARGENTINA OIL CONCESSION
Topics:


Related Articles
GLAXO ANNOUNCES ORGANIZATIONAL REALIGNMENT
PFIZER APPOINTS KAREN L. KATEN EXECUTIVE VICE PRESIDENT OF U.S. PHARMACEUTICALS GROUP
GLAXO INC. NAMES EXECUTIVES TO NEW POSITIONS
ARTHUR M. PAPPAS DEPARTS GLAXO FOR NEW VENTURES
NEW DIRECTOR APPOINTED TO HEAD GLAXO RESEARCH INSTITUTE
MEDAREX ANNOUNCES THE APPOINTMENT OF RANDALL T. CURNOW, M.D. AS SENIOR VICE PRESIDENT AND MEDICAL DIRECTOR
Applied Analytical Industries, Inc. (AAI) Announces Appointment of Dr. Werner Gorlich as General Manager of European Operations
Robert A. Ingram Named Chief Executive Of Glaxo Wellcome plc
North American Scientific hires new COO.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters